Abiopharma

🔍 Conaway Gregory F (Executive)

Company: DEVON ENERGY CORP/DE (DVN)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 18,361 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: A | equity_swap_involved: false | shares_owned_after: 18,361.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: On May 7, 2026, pursuant to the Agreement and Plan of Merger entered into on February 1, 2026, by and among Devon Energy Corporation (''Devon''), Coterra Energy Inc. (''Coterra") and Cubs Merger Sub, Inc. (the ''Merger Agreement''), as of the effective time of the transactions contemplated thereby (the "Effective Time"), Coterra became a wholly owned subsidiary of Devon.
• F2: Pursuant to the Merger Agreement, at the Effective Time, each time-based Coterra restricted stock unit ("Coterra RSU") outstanding and unvested as of immediately prior to the Effective Time was converted into 0.7 Devon time-based restricted stock units ("Devon RSUs"), with each Devon RSU representing a contingent right to receive a share of Devon's common stock, par value $0.10 per share, subject to the same terms and conditions as were applicable to the corresponding Coterra RSU immediately prior to the Effective Time. The Coterra RSUs granted to the reporting person on February 24, 2026 were converted into 18,361 Devon RSUs, which will vest on January 31, 2029.